Evogene Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Evogene Limited with three other
miscellaneous service companies in Middle East:
Clal Biotechnology Industries Limited
sales of 25.01 million Israel Shekels [US$7.01 million]
of which 68%
Redhill Biopharma Ltd
(386,233.09 Israel Shekels [US$108,311.35 ]
(1.70 million Israel Shekels [US$477,572.29 ]
Evogene Limited reported sales of 25.01 million Israel Shekels (US$7.01 million)
December of 2016.
decrease of 42.2%
versus 2015, when the company's sales were 43.25 million Israel Shekels.